From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation

Background: Atrial fibrillation (AF) is the most common arrhythmia diagnosed at an older age. AF is associated with frailty, a condition possibly justifying the higher rate of complications and mortality in aged individuals. This study was aimed at describing the characteristics correlated to frailt...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano Fumagalli, Giulia Ricciardi, Claudia Di Serio, Elisa Berni, Giancarlo La Marca, Giuseppe Pieraccini, Riccardo Romoli, Emanuele Santamaria, Giulia Spanalatte, Camilla Cagnoni, Arianna Tariello, Giada Alla Viligiardi, Agostino Virdis, Igor Diemberger, Andrea Ungar, Niccolò Marchionni
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906724002240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846150091676581888
author Stefano Fumagalli
Giulia Ricciardi
Claudia Di Serio
Elisa Berni
Giancarlo La Marca
Giuseppe Pieraccini
Riccardo Romoli
Emanuele Santamaria
Giulia Spanalatte
Camilla Cagnoni
Arianna Tariello
Giada Alla Viligiardi
Agostino Virdis
Igor Diemberger
Andrea Ungar
Niccolò Marchionni
author_facet Stefano Fumagalli
Giulia Ricciardi
Claudia Di Serio
Elisa Berni
Giancarlo La Marca
Giuseppe Pieraccini
Riccardo Romoli
Emanuele Santamaria
Giulia Spanalatte
Camilla Cagnoni
Arianna Tariello
Giada Alla Viligiardi
Agostino Virdis
Igor Diemberger
Andrea Ungar
Niccolò Marchionni
author_sort Stefano Fumagalli
collection DOAJ
description Background: Atrial fibrillation (AF) is the most common arrhythmia diagnosed at an older age. AF is associated with frailty, a condition possibly justifying the higher rate of complications and mortality in aged individuals. This study was aimed at describing the characteristics correlated to frailty in older AF subjects. Methods: After having excluded a < 3 months major surgery procedure, cancer or other conditions associated with activation of inflammation, and a life expectancy < 12 months, we consecutively enrolled patients ≥ 65 years with persistent AF. They underwent a Comprehensive Geriatric Assessment evaluation. In particular, Mini-Mental State Examination, 15-item Geriatric Depression Scale and Short-Physical Performance Battery (SPPB) described, respectively, cognitive profile, depressive symptoms and physical performance. A venous blood sample was collected to measure interleukin-6 (IL-6; marker of low-grade inflammation) and acylcarnitines, expression of mitochondrial dysfunction and abnormal energy production. Results: Overall, 49 patients (mean age: 76 ± 6 years; women 30.6 %) were studied. Cluster analysis described two different patterns; the second (N = 18, 36.7 %), when compared to the first one (N = 31, 63.3 %), was characterized by a worse phenotype, identified by the simultaneous presence of lower body mass index, higher CHA2DS2-VASc score (index of clinical complexity), worse SPPB functional performance, and high IL-6 levels. Second cluster patients had a higher concentration of 13 of the 35 acylcarnitines evaluated and increased 5-year mortality. All these features can outline a frail condition. Conclusions: Body size, clinical complexity, physical performance and low-grade inflammation seem to rapidly and adequately describe frailty.
format Article
id doaj-art-42c24ed07e2f4a35af7dbe306da13c20
institution Kabale University
issn 2352-9067
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj-art-42c24ed07e2f4a35af7dbe306da13c202024-11-29T06:24:29ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672024-12-0155101558From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillationStefano Fumagalli0Giulia Ricciardi1Claudia Di Serio2Elisa Berni3Giancarlo La Marca4Giuseppe Pieraccini5Riccardo Romoli6Emanuele Santamaria7Giulia Spanalatte8Camilla Cagnoni9Arianna Tariello10Giada Alla Viligiardi11Agostino Virdis12Igor Diemberger13Andrea Ungar14Niccolò Marchionni15Department of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, Italy; Corresponding author at: Department of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Viale Pieraccini 6, 50139 Florence, Italy.Department of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyMass Spectrometry Centre (CISM), University of Florence, Florence, Italy; Newborn Screening, Clinical Chemistry and Pharmacology Lab, Meyer Children’s Hospital IRCCS, Florence, ItalyMass Spectrometry Centre (CISM), University of Florence, Florence, ItalyMass Spectrometry Centre (CISM), University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyDepartment of Medical and Surgical Sciences, DIMEC, University of Bologna, Bologna, Italy; Cardiology Unit, IRCCS Policlinico di S. Orsola, Bologna, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyDepartment of Experimental and Clinical Medicine, Geriatric Intensive Care Unit, University of Florence and AOU Careggi, Florence, ItalyBackground: Atrial fibrillation (AF) is the most common arrhythmia diagnosed at an older age. AF is associated with frailty, a condition possibly justifying the higher rate of complications and mortality in aged individuals. This study was aimed at describing the characteristics correlated to frailty in older AF subjects. Methods: After having excluded a < 3 months major surgery procedure, cancer or other conditions associated with activation of inflammation, and a life expectancy < 12 months, we consecutively enrolled patients ≥ 65 years with persistent AF. They underwent a Comprehensive Geriatric Assessment evaluation. In particular, Mini-Mental State Examination, 15-item Geriatric Depression Scale and Short-Physical Performance Battery (SPPB) described, respectively, cognitive profile, depressive symptoms and physical performance. A venous blood sample was collected to measure interleukin-6 (IL-6; marker of low-grade inflammation) and acylcarnitines, expression of mitochondrial dysfunction and abnormal energy production. Results: Overall, 49 patients (mean age: 76 ± 6 years; women 30.6 %) were studied. Cluster analysis described two different patterns; the second (N = 18, 36.7 %), when compared to the first one (N = 31, 63.3 %), was characterized by a worse phenotype, identified by the simultaneous presence of lower body mass index, higher CHA2DS2-VASc score (index of clinical complexity), worse SPPB functional performance, and high IL-6 levels. Second cluster patients had a higher concentration of 13 of the 35 acylcarnitines evaluated and increased 5-year mortality. All these features can outline a frail condition. Conclusions: Body size, clinical complexity, physical performance and low-grade inflammation seem to rapidly and adequately describe frailty.http://www.sciencedirect.com/science/article/pii/S2352906724002240Atrial fibrillationFrailtyOlder patientsInflammationPhysical performanceAcylcarnitines
spellingShingle Stefano Fumagalli
Giulia Ricciardi
Claudia Di Serio
Elisa Berni
Giancarlo La Marca
Giuseppe Pieraccini
Riccardo Romoli
Emanuele Santamaria
Giulia Spanalatte
Camilla Cagnoni
Arianna Tariello
Giada Alla Viligiardi
Agostino Virdis
Igor Diemberger
Andrea Ungar
Niccolò Marchionni
From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
International Journal of Cardiology: Heart & Vasculature
Atrial fibrillation
Frailty
Older patients
Inflammation
Physical performance
Acylcarnitines
title From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
title_full From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
title_fullStr From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
title_full_unstemmed From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
title_short From geriatric assessment to inflammation. A pilot, observational, study about frailty components in older patients with persistent atrial fibrillation
title_sort from geriatric assessment to inflammation a pilot observational study about frailty components in older patients with persistent atrial fibrillation
topic Atrial fibrillation
Frailty
Older patients
Inflammation
Physical performance
Acylcarnitines
url http://www.sciencedirect.com/science/article/pii/S2352906724002240
work_keys_str_mv AT stefanofumagalli fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT giuliaricciardi fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT claudiadiserio fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT elisaberni fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT giancarlolamarca fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT giuseppepieraccini fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT riccardoromoli fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT emanuelesantamaria fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT giuliaspanalatte fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT camillacagnoni fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT ariannatariello fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT giadaallaviligiardi fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT agostinovirdis fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT igordiemberger fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT andreaungar fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation
AT niccolomarchionni fromgeriatricassessmenttoinflammationapilotobservationalstudyaboutfrailtycomponentsinolderpatientswithpersistentatrialfibrillation